Full Text
The Full Text of this article is available as a PDF (44.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Eggleston P. A., Rosenstein B. J., Stackhouse C. M., Mellits E. D., Baumgardner R. A. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest. 1991 May;99(5):1088–1092. doi: 10.1378/chest.99.5.1088. [DOI] [PubMed] [Google Scholar]
- Erjefält I., Persson C. G. Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand. 1986 Dec;128(4):653–654. doi: 10.1111/j.1748-1716.1986.tb08027.x. [DOI] [PubMed] [Google Scholar]
- Hoiby N., Flensborg E. W., Beck B., Friis B., Jacobsen S. V., Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis. 1977 Apr;58(2):65–79. [PubMed] [Google Scholar]
- Hubbard R. C., McElvaney N. G., Birrer P., Shak S., Robinson W. W., Jolley C., Wu M., Chernick M. S., Crystal R. G. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med. 1992 Mar 19;326(12):812–815. doi: 10.1056/NEJM199203193261207. [DOI] [PubMed] [Google Scholar]
- Kerem E., Reisman J., Corey M., Canny G. J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992 Apr 30;326(18):1187–1191. doi: 10.1056/NEJM199204303261804. [DOI] [PubMed] [Google Scholar]
- Landau L. I., Phelan P. D. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr. 1973 May;82(5):863–868. doi: 10.1016/s0022-3476(73)80085-x. [DOI] [PubMed] [Google Scholar]
- O'Callaghan C. How to get drugs into the respiratory tract. Arch Dis Child. 1993 Apr;68(4):441–443. doi: 10.1136/adc.68.4.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pattishall E. N. Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis. Pediatr Pulmonol. 1990;9(2):80–85. doi: 10.1002/ppul.1950090204. [DOI] [PubMed] [Google Scholar]
- Ramsey B. W., Astley S. J., Aitken M. L., Burke W., Colin A. A., Dorkin H. L., Eisenberg J. D., Gibson R. L., Harwood I. R., Schidlow D. V. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis. 1993 Jul;148(1):145–151. doi: 10.1164/ajrccm/148.1.145. [DOI] [PubMed] [Google Scholar]
- Sanchez I., De Koster J., Holbrow J., Chernick V. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis. Chest. 1993 Sep;104(3):842–846. doi: 10.1378/chest.104.3.842. [DOI] [PubMed] [Google Scholar]
- Sly P. D., Le Souëf P. N. Inhaled therapy in paediatrics. J Paediatr Child Health. 1991 Feb;27(1):7–10. doi: 10.1111/j.1440-1754.1991.tb00337.x. [DOI] [PubMed] [Google Scholar]
- Valerius N. H., Koch C., Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991 Sep 21;338(8769):725–726. doi: 10.1016/0140-6736(91)91446-2. [DOI] [PubMed] [Google Scholar]
- Warner J. O. Immunology of cystic fibrosis. Br Med Bull. 1992 Oct;48(4):893–911. doi: 10.1093/oxfordjournals.bmb.a072584. [DOI] [PubMed] [Google Scholar]
- Weintraub S. J., Eschenbacher W. L. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF. Chest. 1989 Apr;95(4):861–864. doi: 10.1378/chest.95.4.861. [DOI] [PubMed] [Google Scholar]
- Wood R. E., Wanner A., Hirsch J., Farrell P. M. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis. 1975 Jun;111(6):733–738. doi: 10.1164/arrd.1975.111.6.733. [DOI] [PubMed] [Google Scholar]